GlassScriptPhysician profile
Dipali S Patel
NPI 1467892828
$469.51
in general payments reported to CMS, 2019-2025
9 companies · $78.90 in 2025
The $78.90 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.04 · 2021: $32.36 · 2022: $83.76 · 2023: $180 · 2024: $17.48 · 2025: $78.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $231 · Education: $39.33 · Travel and Lodging: $5.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $231.21 |
| Education | $39.33 |
| Travel and Lodging | $5.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $179.97 | 2023 | Senza |
| Dentsply Ih INC. | $60.77 | 2019 | |
| Abbott Laboratories | $57.05 | 2025 | Proclaim |
| Stimwave Technologies Incorporated | $50.18 | 2022 | |
| Colgate Oral Pharmaceuticals, INC. | $39.33 | 2024-2025 | |
| Align Technology, INC. | $32.81 | 2021-2022 | |
| Kulzer, LLC | $17.57 | 2021 | |
| Dexcel Pharma Technologies LTD. | $16.27 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $15.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dipali Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.